MoBiTec GmbH

MoBiTec is dedicated to developing, producing and marketing unique tools for molecular and cell biology. We use new technologies that have been invented at leading research facilities including the German Max-Planck Institutes. Reflecting this arrangement, our first product line was an extensive range of immobilized enzymes in Compact Reaction Columns (CRCs). These were developed at MoBiTec using chemistry patented by the Max-Plank Society. Our next product, the pAX vectors, were a range of fusion protein vectors. These were the first on the market and were developed together with researchers at the Max-Planck Institute for Experimental Medicine and Goettingen’s Georg August University.
As an intergral part of its global focus, MoBiTec has been operating extensively with scientists all over Europe and North America, including those from the Pasteur Institute in France and Vrije University in the Netherlands. By commercializing the brilliant ideas of many researchers, we are able to offer a unique range of high quality products with simplified protocols making lab life easier and leaving more time for research.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Enzymes
- Proteins

Therapeutic targets:

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: 1987